Miao Yan, Xu Si-Yi, Chen Lu-Si, Liang Ge-Yu, Pu Yue-Pu, Yin Li-Hong
Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Oncotarget. 2017 Sep 12;8(47):83114-83127. doi: 10.18632/oncotarget.20851. eCollection 2017 Oct 10.
PURPOSE: This study aims to analyze the scientific output of long noncoding RNA (lncRNA) research and construct a model to evaluate publications from the past decade qualitatively and quantitatively. METHODS: Publications from 2007 to 2016 were retrieved from the Web of Science Core Collection database. Microsoft Excel 2016 and CiteSpace IV software were used to analyze publication outputs, journals, countries, institutions, authors, citation counts, ESI top papers, H-index, and research frontiers. RESULTS: A total of 3,008 papers on lncRNA research were identified published by June 17, 2017. The journal, (IF2016, 5.168) ranked first in the number of publications. China had the largest number of publications (1,843), but the United States showed its dominant position in both citation frequency (45,120) and H-index (97). Zhang Y (72 publications) published the most papers, and Guttman M (1,556 citations) had the greatest co-citation counts. The keyword "database" ranked first in research frontiers. CONCLUSION: The annual number of publications rapidly increased in the past decade. China showed its significant progress in lncRNA research, but the United States was the actual leading country in this field. Many Chinese institutions engaged in lncRNA research but significant collaborations among them were not noted. Guttman M, Mercer TR, Rinn JL, and Gupta RA were identified as good candidates for research collaboration. "Database," "Xist RNA," and "Genome-wide association study" should be closely observed in this field.
Oncotarget. 2017-9-12
Medicine (Baltimore). 2017-5
Channels (Austin). 2018
Front Biosci (Landmark Ed). 2022-8-31
Channels (Austin). 2020-12
Int J Impot Res. 2020-7
Int J Gen Med. 2024-9-11
Acta Neuropathol. 2024-8-29
Int J Chron Obstruct Pulmon Dis. 2023
Hum Vaccin Immunother. 2023-12-31
Front Public Health. 2022
Onco Targets Ther. 2017-6-1
Int J Mol Sci. 2017-6-9
Oncotarget. 2016-7-12